Clinical Trial Update: Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) [Phase 2]

View source ↗

Summary

Phase 2 trial of rADAMTS-13 (SHP655) for acquired thrombotic thrombocytopenic purpura (aTTP) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• rADAMTS-13 (SHP655) (rADAMTS-13)

Snippet

Sponsor: Shire | Conditions: Acquired Thrombotic Thrombocytopenic Purpura (aTTP) | Phase 2 | Status: COMPLETED | Results posted: 2022-12-01